FASN multi-omic characterization reveals metabolic heterogeneity in pancreatic and prostate adenocarcinoma

Ugo Chianese,Chiara Papulino,Ahmad Ali,Fortunato Ciardiello,Salvatore Cappabianca,Lucia Altucci,Vincenzo Carafa,Rosaria Benedetti
DOI: https://doi.org/10.1186/s12967-023-03874-5
IF: 8.44
2023-01-19
Journal of Translational Medicine
Abstract:Pancreatic ductal adenocarcinoma (PDAC) and prostate cancer (PCa) are among the most prevalent malignant tumors worldwide. There is now a comprehensive understanding of metabolic reprogramming as a hallmark of cancer. Fatty acid synthase (FASN) is a key regulator of the lipid metabolic network, providing energy to favor tumor proliferation and development. Whereas the biological role of FASN is known, its response and sensitivity to inhibition have not yet been fully established in these two cancer settings.
medicine, research & experimental
What problem does this paper attempt to address?